<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-1862</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИКА И ФАРМАКОТЕРАПИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>GUIDELINES FOR THE PRACTITIONER</subject></subj-group></article-categories><title-group><article-title>КЛИНИЧЕСКАЯ ЭФФЕКТИВНОСТЬ И ВАЗОПРОТЕКТИВНОЕ ДЕЙСТВИЕ ПРЕПАРАТОВ ИЗ ГРУППЫ ИНГИБИТОРОВ АПФ И БЕТА-АДРЕНОБЛОКАТОРОВ У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>Clinical efficacy and vasoprotection of ACE inhibitors and beta3blockers in patients with arterial hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Намсараев</surname><given-names>Ж. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Namsaraev</surname><given-names>Zh. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тхостова</surname><given-names>Е. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkhostova</surname><given-names>E. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Леонова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Leonova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белоусов</surname><given-names>Ю. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Belousov</surname><given-names>Yu. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абильдинова</surname><given-names>А. Ж.</given-names></name><name name-style="western" xml:lang="en"><surname>Abildinova</surname><given-names>A. Zh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глезер</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Glezer</surname><given-names>M. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра клинической фармакологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Российский государственный медицинский университет</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2004</year></pub-date><volume>0</volume><issue>1</issue><fpage>38</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Намсараев Ж.Н., Тхостова Е.Б., Леонова М.В., Белоусов Ю.Б., Абильдинова А.Ж., Глезер М.Г., 2004</copyright-statement><copyright-year>2004</copyright-year><copyright-holder xml:lang="ru">Намсараев Ж.Н., Тхостова Е.Б., Леонова М.В., Белоусов Ю.Б., Абильдинова А.Ж., Глезер М.Г.</copyright-holder><copyright-holder xml:lang="en">Namsaraev Z.N., Tkhostova E.B., Leonova M.V., Belousov Y.B., Abildinova A.Z., Glezer M.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/1862">https://russjcardiol.elpub.ru/jour/article/view/1862</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lind L., Grantsam S., Millgard J. Endothelium-dependent vasodilation in hypertension -A review. Blood Pressure. 2000; 9: 4-15.</mixed-citation><mixed-citation xml:lang="en">Lind L., Grantsam S., Millgard J. Endothelium-dependent vasodilation in hypertension -A review. Blood Pressure. 2000; 9: 4-15.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Vanhoutte P.M., Boulanger С.М., Mombouli J.V. Endothelium-derivative relaxing genes and inhibition of an enzyme of conversion. J. Cardiol. 1995; 24; 76 (15): 3E-12E.</mixed-citation><mixed-citation xml:lang="en">Vanhoutte P.M., Boulanger С.М., Mombouli J.V. Endothelium-derivative relaxing genes and inhibition of an enzyme of conversion. J. Cardiol. 1995; 24; 76 (15): 3E-12E.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Van Zweiten P.A. Endothelial dysfunction in hypertension. A critical evaluation. Blood Press Suppl. 1997; 2: 6770.</mixed-citation><mixed-citation xml:lang="en">Van Zweiten P.A. Endothelial dysfunction in hypertension. A critical evaluation. Blood Press Suppl. 1997; 2: 6770.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Taddei S., Virdis A., Chiadoni L., et al. The role of endothelium in human hypertension. Curr. Opin. Nephrol. Hypertens. 1998 Mar; 7(2): 2039.</mixed-citation><mixed-citation xml:lang="en">Taddei S., Virdis A., Chiadoni L., et al. The role of endothelium in human hypertension. Curr. Opin. Nephrol. Hypertens. 1998 Mar; 7(2): 2039.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Noll G., Tschudi M., Nava E., et al. Endothelium and high blood pressure. Int. J. Microcirc. Clin. Exp. 1997 Oct; 17(5): 2739.</mixed-citation><mixed-citation xml:lang="en">Noll G., Tschudi M., Nava E., et al. Endothelium and high blood pressure. Int. J. Microcirc. Clin. Exp. 1997 Oct; 17(5): 2739.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Vanhoutte P.M. Endothelial dysfunction and inhibition of converting enzyme. Eur. Heart. J. 1998; 19: 7-16.</mixed-citation><mixed-citation xml:lang="en">Vanhoutte P.M. Endothelial dysfunction and inhibition of converting enzyme. Eur. Heart. J. 1998; 19: 7-16.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson T.J., Elstein E., Haber H., et al. Comparative study of ACE-Inhibition, angiotensin II antagonism, and calcium channel blockade on flow mediated vasodilatation in patients with coronary disease. BANFF Study. J. Am. Coll. Cardiol. 2000; 35: 60-6.</mixed-citation><mixed-citation xml:lang="en">Anderson T.J., Elstein E., Haber H., et al. Comparative study of ACE-Inhibition, angiotensin II antagonism, and calcium channel blockade on flow mediated vasodilatation in patients with coronary disease. BANFF Study. J. Am. Coll. Cardiol. 2000; 35: 60-6.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Tang R., Hennig M., Thomasson B., et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J. Hypertens. 2000; 18(2): 197-201.</mixed-citation><mixed-citation xml:lang="en">Tang R., Hennig M., Thomasson B., et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J. Hypertens. 2000; 18(2): 197-201.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Simon, et al. Differential effects of nifedipin and co-amilozid on the progression of early carotid wall changes. Cirс. 2001; 103: 2949-2954.</mixed-citation><mixed-citation xml:lang="en">Simon, et al. Differential effects of nifedipin and co-amilozid on the progression of early carotid wall changes. Cirс. 2001; 103: 2949-2954.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nikolaos T., Pitt O. Lim, Thomas M. MacDonald. Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension. A Randomized, Double Blind, Crossover Study. Cirс. 2001; 104: 511.</mixed-citation><mixed-citation xml:lang="en">Nikolaos T., Pitt O. Lim, Thomas M. MacDonald. Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension. A Randomized, Double Blind, Crossover Study. Cirс. 2001; 104: 511.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hulthe J., Wikstrand J., Emanuelsson H., et al. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke. 1997; 28: 1189-1194.</mixed-citation><mixed-citation xml:lang="en">Hulthe J., Wikstrand J., Emanuelsson H., et al. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke. 1997; 28: 1189-1194.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly J. Hunt, PhD., Greg W. Evans, M.A., Aaron R. Folsom, et al. Acoustic Shadowing on B-Mode Ultrasound of the Carotid Artery Predicts Ischemic Stroke. The Atherosclerosis Risk in Communities (ARIC). Study Stroke. 2001; 32: 1120.</mixed-citation><mixed-citation xml:lang="en">Kelly J. Hunt, PhD., Greg W. Evans, M.A., Aaron R. Folsom, et al. Acoustic Shadowing on B-Mode Ultrasound of the Carotid Artery Predicts Ischemic Stroke. The Atherosclerosis Risk in Communities (ARIC). Study Stroke. 2001; 32: 1120.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nelermajer D.S., Sorensen K.E., Bull C., et al. Endothelium-dependent dilatation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J.A.M. Coll. Cardiol. 1994; 24: 1468-1474.</mixed-citation><mixed-citation xml:lang="en">Nelermajer D.S., Sorensen K.E., Bull C., et al. Endothelium-dependent dilatation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J.A.M. Coll. Cardiol. 1994; 24: 1468-1474.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
